Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements and Implementation of Cease Trade Order
August 08, 2025 18:28 ET | Source: Aja Health and Wellness Inc.…
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1…
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
Recorded second quarter 2025 worldwide revenue of $378.0 million, GAAP fully diluted…
Cango Inc. Announces July 2025 Bitcoin Production and Mining Operations Update
HONG KONG, Aug. 5, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango"…
Sirona Biochem Update to Shareholders on Financial Status and Operations
August 01, 2025 16:30 ET | Source: Sirona Biochem Corp. VANCOUVER, British…
NYSE Content Advisory: Pre-market update + Ambiq raises $96 million in IPO
NEW YORK, July 30, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-market update + Wall Street anticipates Fed’s next move
NEW YORK, July 29, 2025 /PRNewswire/ -- The New York Stock Exchange…
NYSE Content Advisory: Pre-market update + U.S. & EU reach trade deal
NEW YORK, July 28, 2025 /PRNewswire/ -- The New York Stock Exchange…
Recognify Life Sciences Provides Update on Phase 2b Trial of Inidascamine in Patients with Cognitive Impairment Associated with Schizophrenia
July 25, 2025 16:05 ET | Source: atai Life Sciences Initial results…
